Abstract
Women taking HT may experience symptoms related to estrogen excess. Symptoms include nausea, weight gain, breast tenderness, and enlargement. Other symptoms include premenstrual syndrome and heavier or light menstrual bleeding. Intermenstrual spotting may occur with continuous estradiol and progesterone.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Bibliography
Campbell Jenkins BW, Addison C, Wilson G, et al. Association of the joint effect of menopause and hormone replacement therapy and cancer in African American women: the Jackson Heart Study. Int J Environ Res Public Health. 2011;8: 2491–504.
Canonico M, Plu-Bureau, Scarabin P-V. Progestogens and venous thromboembolism among postmenopausal women using hormone therapy. Maturitas. 2011;70:354–60.
Carcaillon L, GarcĂa-GarcĂa FJ, Tresguerres JAF, et al. Higher levels of endogenous estradiol are associated with frailty in postmenopausal women from the Toledo Study for Healthy Aging. J Clin Endocrinol Metab. 2012;97(8):2898–906.
MacLennan AH. HRT in difficult circumstances: are there any absolute contraindications? Climacteric. 2011;14:409–17.
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer Science+Business Media New York
About this chapter
Cite this chapter
Sherif, K. (2013). Hormone Therapy: Monitoring Effects and Side Effects. In: Hormone Therapy. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-6268-2_10
Download citation
DOI: https://doi.org/10.1007/978-1-4614-6268-2_10
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4614-6267-5
Online ISBN: 978-1-4614-6268-2
eBook Packages: MedicineMedicine (R0)